Common Back-Pain Drug May Be Linked to Higher Dementia Risk, Large Study Finds

๐Ÿ“‰ Key Findings:

Group

Increased Risk

All adults taking โ‰ฅ6 prescriptions

โž• 29% higher risk of dementia<br>โž• 85% higher risk of mild cognitive impairment (MCI) within 10 years

Adults aged 35โ€“49

๐Ÿ”บ More than double the risk of dementia<br>๐Ÿ”บ Over triple the risk of MCI

Adults aged 50โ€“64

Significantly elevated risk โ€” nearly matching younger group

Adults 18โ€“34

No significant increase found

๐Ÿ‘‰ The longer and more frequently people used gabapentin, the greater the cognitive risk.

And shockingly, the highest dangers werenโ€™t in older adultsโ€”but in those in their 30s, 40s, and 50s, who are decades away from typical dementia onset.

๐Ÿ’Š What Is Gabapentin?

Originally developed as an anti-seizure medication, gabapentin (brand names Neurontin, Gralise, Horizant) is now widely prescribed off-label for:

Chronic back and nerve pain

Sciatica

Fibromyalgia

Restless leg syndrome

Anxiety and sleep issues (though not FDA-approved for these)

Why it’s popular:

Not addictive like opioids

Often covered by insurance

Generally well-tolerated short-term

But this new research suggests that long-term use may come with hidden neurological costs.

๐Ÿง  Why Might Gabapentin Affect the Brain?

While the exact mechanism isnโ€™t fully understood, experts believe several factors may play a role: